Knocking down FRK in the immortalized non-tumorigenic mammary epithelial cell line, MCF10A, induced transformation [13, 14]; while, exogenous expression of FRK in breast and brain cancer cells inhibited cell proliferation, migration and invasiveness [13, 15, 16]. The gene discussed is FRK; the disease is brain cancer.